Initial clinical experience with distal protection using the filterwire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention

Catheterization and Cardiovascular Interventions

Volumn 57, Issue 2, 2002, Pages 125-134

  Popma, Jeffrey J ^a   Cox, Nicholas ^a   Hauptmann, K Eugene ^b   Reifart, Nicolaus ^c   Virmani, Renu ^d   Emira, Khaled ^a   Murphy, Sabina ^e   Gibson, C Michael ^e   Grube, Eberhard ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^c Main Taunus Heart Institute   (Germany)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^e HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^f Heart Center   (Germany)

Author keywords

Distal protection; Saphenous vein graft; Stenting

Indexed keywords

CREATINE KINASE MB; POLYURETHAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEVICE; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MICROEMBOLISM; PARTICLE SIZE; POSTOPERATIVE COMPLICATION; Q WAVE; SAFETY; SAPHENOUS VEIN GRAFT; SURGICAL MORTALITY; TREATMENT OUTCOME;

AGED; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; EMBOLISM; FEASIBILITY STUDIES; FEMALE; FILTRATION; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PARTICLE SIZE; RETROSPECTIVE STUDIES; SAPHENOUS VEIN;

EID: 0036792761     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10313     Document Type: Article

References (27)

1. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-1549.
2. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB, 3rd, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts: Saphenous Vein De Novo Trial investigators. N Engl J Med 1997;337:740-747.
3. Detre K, Holubkov R, Kelsey S, Bourassa M, Williams D, Holmes D Jr, et al. One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's percutaneous transluminal coronary angioplasty registry. Circulation 1989;80:421-428.
4. Topol E, Yadav J. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
5. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months: the EPIC investigators. Lancet 1994;343:881-886.
6. Ellis S, Lincoff A, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998;32:1619-1623.
7. Webb J, Carere R, Virmani R, Bairn D, Teirstein P, Whitlow P, et al. Retrieval and analysis of particulate debris follow saphenous vein graft intervention. J Am Coll Cardiol 1999;34:461-467.
8. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KKL, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous interventional of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:13-18.
9. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
10. Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, et al. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 1994;89:882-892.
11. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. J Am Coll Cardiol 1994;24:216-224.
12. Lefkovits J, Holmes DR, Califf RM, Safian RD, Pieper K, Keeler G, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy trial. Circulation 1995;92:734-740.
13. Kaplan B, Gregory M, Schreiber T, Rizik D, Masden R, Brown C, et al. Transluminal extraction atherectomy versus balloon angioplasty in acute ischemic syndromes: An interim analysis of the TOPIT trial. Circulation 1996;94:1317.
14. Baim D, Carrozza J. Understanding the "no-reflow" problem. Cathet Cardiovasc Diagn 1996;1:7-8.
15. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
16. Trono R, Sutton C, Hollman J, Suit P, Ratliff N. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts. Cleve Clin J Med 1989;56:581-584.
17. Abdelmeguid AE, Whitlow PL, Sapp SK, Ellis SG, Topol EJ. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation 1995;91:2733-2741.
18. Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 1996;131:1097-1105.
19. Abdelmeguid A, Topol E. The myth of the myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation 1996;1996:3369-3375.
20. Bourassa MG, Wilson JW, Detre KM, Kelsey SF, Robertson T, Passamani ER. Long-term follow-up of coronary angioplasty: the 1977-1981 National Heart, Lung, and Blood Institute registry. Eur Heart J 1989;10:36-41.
21. Campeau L, Enjalbert M, Lesperance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. N Engl J Med 1984;311:1329-1332.
22. Walts A, Fishbein M, Sustaite H, Martloff J. Ruptured atheromatous plaques in saphenous vein coronary bypass graft: a mechanism of acute, thrombotic, late graft occlusion. Circulation 1982;65:197-201.
23. Waller B, Rothbaum D, Gorfinkel H, Ulbright T, Linnemeier T, Berger S. Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein grafts. J Am Coll Cardiol 1984;4:784-792.
24. Hong M, Mehran R, Dangas G, et al. Creatine-kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;1000:2400-2405.
25. Hong MK, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al. Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J 1994;127:1496-1503.
26. Belli G, Pezzano A, De Biase AM, Bonacina E, Silva P, Salvade P, et al. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Cathet Cardiovasc Intervent 2000;50:362-370.
27. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, Ito H, Kitabatake A, Sato T, Kamada T. Role of adenosine in hypermic response of coronary blood flow in microembolization. Am J Physiol 1986;250:H509.